Presentation is loading. Please wait.

Presentation is loading. Please wait.

Macroscopic observations of the mogamulizumab-induced skin-related AEs

Published byKarolina Isaksson Modified over 4 years ago

Similar presentations

Presentation on theme: "Macroscopic observations of the mogamulizumab-induced skin-related AEs"— Presentation transcript:

1 Macroscopic observations of the mogamulizumab-induced skin-related AEs
Macroscopic observations of the mogamulizumab-induced skin-related AEs. A and B, Macroscopic appearance of vitiligo nearly one year after the day the patient was diagnosed with mogamulizumab-induced erythema multiforme with anti-melanocyte antibodies. Macroscopic observations of the mogamulizumab-induced skin-related AEs. A and B, Macroscopic appearance of vitiligo nearly one year after the day the patient was diagnosed with mogamulizumab-induced erythema multiforme with anti-melanocyte antibodies. C, Bullous lesions of another ATL patient after mogamulizumab treatment. Yui Suzuki et al. Clin Cancer Res 2019;25: ©2019 by American Association for Cancer Research

Download ppt "Macroscopic observations of the mogamulizumab-induced skin-related AEs"

Similar presentations

PI 3-kinase inhibition has no effect on ANG II induced extracellular recognition kinase (ERK) 1/2 activation. PI 3-kinase inhibition has no effect on ANG.

PI 3-kinase inhibition has no effect on ANG II induced extracellular recognition kinase (ERK) 1/2 activation. PI 3-kinase inhibition has no effect on ANG.
Rearrangements of Gene A and Gene B

Rearrangements of Gene A and Gene B
Treatment of human MCC tumors with intralesional IFNβ is associated with MHC-I upregulation. Treatment of human MCC tumors with intralesional IFNβ is associated.

Treatment of human MCC tumors with intralesional IFNβ is associated with MHC-I upregulation. Treatment of human MCC tumors with intralesional IFNβ is associated.
Gr-1+ MDSC in tumor-bearing mice produce IL-6.

Gr-1+ MDSC in tumor-bearing mice produce IL-6.
Kinetic changes of sPD-L1 and cytokines, and kinetic radiographic reduction in tumor size after ipilimumab plus bevacizumab treatment. Kinetic changes.

Kinetic changes of sPD-L1 and cytokines, and kinetic radiographic reduction in tumor size after ipilimumab plus bevacizumab treatment. Kinetic changes.
Cumulative incidence of (A) ESRD, (B) all-cause death, (C) all-cause death without ESRD and (D) ESRD or all-cause death in patients with T1DM diagnosed.

Cumulative incidence of (A) ESRD, (B) all-cause death, (C) all-cause death without ESRD and (D) ESRD or all-cause death in patients with T1DM diagnosed.
Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.
Serial measurements of serum glucose, anion gap, serum carbon dioxide, and serum triglycerides throughout the patient's hospital stay. Serial measurements.

Serial measurements of serum glucose, anion gap, serum carbon dioxide, and serum triglycerides throughout the patient's hospital stay. Serial measurements.
Recognition of naturally processed HTLV-1 Tax protein derived from HAM patient's PBMC. A, HTLV-1 Tax protein content was evaluated by Western blot analysis.

Recognition of naturally processed HTLV-1 Tax protein derived from HAM patient's PBMC. A, HTLV-1 Tax protein content was evaluated by Western blot analysis.
IL32 is highly expressed in mycosis fungoides lesional skin.

IL32 is highly expressed in mycosis fungoides lesional skin.
Suppression by nobiletin of TPA-induced skin morphological changes observed by H&E staining. Suppression by nobiletin of TPA-induced skin morphological.

Suppression by nobiletin of TPA-induced skin morphological changes observed by H&E staining. Suppression by nobiletin of TPA-induced skin morphological.
Development of SCLCs in B5 (AJ × Trp53F2-10/F2-10;Rb1F19/F19) mice.

Development of SCLCs in B5 (AJ × Trp53F2-10/F2-10;Rb1F19/F19) mice.
A, Overall survival of patients treated with CAR T cells (black line; n = 15). A, Overall survival of patients treated with CAR T cells (black line; n.

A, Overall survival of patients treated with CAR T cells (black line; n = 15). A, Overall survival of patients treated with CAR T cells (black line; n.
Effect of anti-CYP3A and anti-CYP2C antibodies on the disappearance of MPA in human liver microsomes (GHL24). Effect of anti-CYP3A and anti-CYP2C antibodies.

Effect of anti-CYP3A and anti-CYP2C antibodies on the disappearance of MPA in human liver microsomes (GHL24). Effect of anti-CYP3A and anti-CYP2C antibodies.
Anti-Flk-1 treatment inhibits growth of s. c. 4T1 and B16 tumors. s. c

Anti-Flk-1 treatment inhibits growth of s. c. 4T1 and B16 tumors. s. c
Effect of nicotinamide and carbogen on 5-FU uptake (measured as SUV3

Effect of nicotinamide and carbogen on 5-FU uptake (measured as SUV3
A and B, images from a patient with an invasive carcinoma on the floor of the mouth. A and B, images from a patient with an invasive carcinoma on the floor.

A and B, images from a patient with an invasive carcinoma on the floor of the mouth. A and B, images from a patient with an invasive carcinoma on the floor.
Vascular staining in CWR22R xenograft tumors.

Vascular staining in CWR22R xenograft tumors.
VEGF expression in neoplastic and normal prostate tissue.

VEGF expression in neoplastic and normal prostate tissue.
Predictive value of the FGFR3 mutation assay increases with multiple consecutive FGFR3-positive urine samples. Predictive value of the FGFR3 mutation assay.

Predictive value of the FGFR3 mutation assay increases with multiple consecutive FGFR3-positive urine samples. Predictive value of the FGFR3 mutation assay.

Similar presentations

Ads by Google